Considering the strategic role played by α7 nAChRs in modulating the “cholinergic anti-inflammatory pathway”, we have also evaluated its potential protective effects on OPCs and OLs in inflammatory conditions, a state typically present in the CNS in the presence of neurodegenerative or demyelinating diseases. The gene discussed is CHRNA7; the disease is demyelinating disease.